Article info

PDF

Original article
Long-term use of adalimumab as monotherapy after attainment of low disease activity with adalimumab plus methotrexate in patients with rheumatoid arthritis

Authors

  1. Correspondence to Dr Edward C Keystone; ed.keystone{at}sinaihealthsystem.ca
View Full Text

Citation

Keystone EC, Breedveld FC, Kupper H, et al
Long-term use of adalimumab as monotherapy after attainment of low disease activity with adalimumab plus methotrexate in patients with rheumatoid arthritis

Publication history

  • Received December 20, 2017
  • Revision received April 24, 2018
  • Accepted April 25, 2018
  • First published June 13, 2018.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.